AU2004204734B2 - Contact lens and eye drop rewetter compositions and their uses - Google Patents

Contact lens and eye drop rewetter compositions and their uses Download PDF

Info

Publication number
AU2004204734B2
AU2004204734B2 AU2004204734A AU2004204734A AU2004204734B2 AU 2004204734 B2 AU2004204734 B2 AU 2004204734B2 AU 2004204734 A AU2004204734 A AU 2004204734A AU 2004204734 A AU2004204734 A AU 2004204734A AU 2004204734 B2 AU2004204734 B2 AU 2004204734B2
Authority
AU
Australia
Prior art keywords
stable ophthalmic
ophthalmic composition
composition
preferred
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2004204734A
Other languages
English (en)
Other versions
AU2004204734A1 (en
Inventor
James N. Cook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Johnson and Johnson Surgical Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Surgical Vision Inc filed Critical Johnson and Johnson Surgical Vision Inc
Publication of AU2004204734A1 publication Critical patent/AU2004204734A1/en
Application granted granted Critical
Publication of AU2004204734B2 publication Critical patent/AU2004204734B2/en
Assigned to Abbott Medical Optics Inc. reassignment Abbott Medical Optics Inc. Request to Amend Deed and Register Assignors: Refer to Publication History
Assigned to Abbott Medical Optics Inc. reassignment Abbott Medical Optics Inc. Request to Amend Deed and Register Assignors: Refer to Publication History
Assigned to Johnson & Johnson Surgical Vision, Inc. reassignment Johnson & Johnson Surgical Vision, Inc. Request to Amend Deed and Register Assignors: Abbott Medical Optics Inc.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AU2004204734A 2003-01-08 2004-01-08 Contact lens and eye drop rewetter compositions and their uses Expired AU2004204734B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43885703P 2003-01-08 2003-01-08
US43884303P 2003-01-08 2003-01-08
US60/438,843 2003-01-08
US60/438,857 2003-01-08
PCT/US2004/000298 WO2004062660A1 (en) 2003-01-08 2004-01-08 Contact lens and eye drop rewetter compositions and their uses

Publications (2)

Publication Number Publication Date
AU2004204734A1 AU2004204734A1 (en) 2004-07-29
AU2004204734B2 true AU2004204734B2 (en) 2008-04-10

Family

ID=32718011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004204734A Expired AU2004204734B2 (en) 2003-01-08 2004-01-08 Contact lens and eye drop rewetter compositions and their uses

Country Status (8)

Country Link
US (3) US20040137079A1 (enExample)
EP (1) EP1581211A1 (enExample)
JP (1) JP2006516032A (enExample)
AU (1) AU2004204734B2 (enExample)
BR (1) BRPI0406636A (enExample)
CA (1) CA2512320A1 (enExample)
TW (1) TWI339747B (enExample)
WO (1) WO2004062660A1 (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2527712C (en) 2003-06-13 2014-08-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7722808B2 (en) 2003-09-12 2010-05-25 Novartis Ag Method and kits for sterilizing and storing soft contact lenses
US20050202983A1 (en) * 2004-03-12 2005-09-15 Erning Xia Prevention of loss of tight cell junctions using carbohydrate-containing compositions
US7544671B2 (en) * 2004-05-07 2009-06-09 S.K. Pharmaceuticals, Inc. Stabilized hyaluronan preparations and related methods
US8288362B2 (en) 2004-05-07 2012-10-16 S.K. Pharmaceuticals, Inc. Stabilized glycosaminoglycan preparations and related methods
ATE452659T1 (de) * 2004-10-01 2010-01-15 Menicon Co Ltd Verfahren zur sterilisation verpackter kontaktlinsen mit verpackungslösung
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US9297928B2 (en) 2004-11-22 2016-03-29 Johnson & Johnson Vision Care, Inc. Ophthalmic compositions comprising polyether substituted polymers
EP4176906A1 (en) 2005-02-14 2023-05-10 Johnson & Johnson Vision Care, Inc. A comfortable ophthalmic device and methods of its production
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
ES2285910B1 (es) * 2005-09-08 2008-12-16 Vicente Tormo Maicas Procedimiento para la elaboracion de la formula de hialuronato sodico para la curacion y cicatrizacion de heridas.
US9052529B2 (en) 2006-02-10 2015-06-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
AR062046A1 (es) * 2006-07-25 2008-08-10 Osmotica Pharmaceutical Argentina S A Soluciones oftalmicas
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US20080141628A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Packaging Solutions
US20080166393A1 (en) * 2007-01-05 2008-07-10 Grant Robert K Eye Medication Delivery System
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
TWI551305B (zh) * 2007-08-31 2016-10-01 諾華公司 相對黏稠封裝溶液之用途
WO2009032122A1 (en) 2007-08-31 2009-03-12 Novartis Ag Contact lens packaging solutions
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
WO2010003797A1 (en) * 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
WO2010009064A2 (en) 2008-07-15 2010-01-21 Basf Corporation Non-cytotoxic chlorine dioxide fluids
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
EP2346513A1 (en) * 2008-09-15 2011-07-27 Bausch & Lomb Incorporated Compositions comprising polymers having amino sugar units and methods of making and using same
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US8311625B2 (en) 2009-02-04 2012-11-13 Basf Corporation Chlorine dioxide treatment for biological tissue
IT1394223B1 (it) 2009-05-15 2012-06-01 Thea Sas Lab Kit per la valutazione e la selezione personalizzata di lacrime artificiali
JP5601805B2 (ja) * 2009-08-24 2014-10-08 キユーピー株式会社 経口用ドライアイ改善剤、ならびに前記経口用ドライアイ改善剤を含む食品組成物および医薬品組成物
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
AT511164A1 (de) 2011-03-03 2012-09-15 Croma Pharma Gmbh Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2787969B1 (en) 2011-12-07 2021-09-29 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
EP2816996B1 (en) 2012-02-24 2016-10-05 Bausch & Lomb Incorporated Ophthalmic compositions with alkoxylated natural waxes
LT2950783T (lt) * 2013-02-01 2019-10-25 Allergan Inc Dirbtinės ašaros, kurių sudėtyje yra natrio hialuronato ir karboksimetilceliuliozės
WO2016013993A1 (en) 2014-07-25 2016-01-28 Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. Stable preservative free ophthalmic formulations of opioid antagonists
EP3223794A1 (en) 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
KR102648671B1 (ko) 2015-12-03 2024-03-19 알콘 인코포레이티드 콘택트 렌즈 포장 용액
TWI609957B (zh) 2016-06-27 2018-01-01 晶碩光學股份有限公司 用以處理隱形眼鏡之溶液及隱形眼鏡的包裝系統
IT201700009786A1 (it) * 2017-01-30 2018-07-30 For Health Pharma S R L Sostituto lacrimale
JP7104553B2 (ja) * 2018-03-30 2022-07-21 ロート製薬株式会社 眼科組成物
TW202014194A (zh) 2018-04-27 2020-04-16 美商歐樂根公司 抗微生物功效增強且毒性降低之亞氯酸鈉組成物
CN112741105A (zh) * 2019-10-30 2021-05-04 永胜光学股份有限公司 具有高效抗微生物能力与润滑效果的溶液
TWI821845B (zh) * 2021-12-29 2023-11-11 永勝光學股份有限公司 應用於眼用鏡片的溶液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000019981A1 (en) * 1998-10-08 2000-04-13 Karagoezian Hampar L Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4478189A (en) * 1982-12-08 1984-10-23 Lucas Industries Fuel injection system
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IL92351A (en) * 1988-11-29 1994-02-27 Allergan Inc Irvine Aqueous opthalmic solutions containing stabilized chlorine dioxide and an inorganic salt
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
JP4927298B2 (ja) * 2000-07-14 2012-05-09 アラーガン、インコーポレイテッド α−２−アドレナリンアゴニスト成分を含有する組成物
AU2001273268B2 (en) * 2000-07-14 2005-08-25 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
DE10038955C2 (de) * 2000-08-09 2002-07-11 Infineon Technologies Ag Verfahren zur Herstellung eines Bipolartransistors
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
JP3455852B2 (ja) * 2000-12-26 2003-10-14 株式会社オフテクス 洗眼液組成物
JP2004521682A (ja) * 2001-01-09 2004-07-22 ルーイ・ヨハン・ワヘナール 眼を治療および／またはケアする方法と組成物
AR034371A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000019981A1 (en) * 1998-10-08 2000-04-13 Karagoezian Hampar L Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide

Also Published As

Publication number Publication date
AU2004204734A1 (en) 2004-07-29
JP2006516032A (ja) 2006-06-15
US20040137079A1 (en) 2004-07-15
EP1581211A1 (en) 2005-10-05
TW200419217A (en) 2004-10-01
CA2512320A1 (en) 2004-07-29
BRPI0406636A (pt) 2005-12-06
US20050266089A1 (en) 2005-12-01
US20050260280A1 (en) 2005-11-24
TWI339747B (en) 2011-04-01
WO2004062660A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
US20040137079A1 (en) Contact lens and eye drop rewetter compositions and methods
JP5514547B2 (ja) 眼科用組成物
JP5797720B2 (ja) 眼科用組成物
CN106456536A (zh) 水性眼用溶液和治疗干眼综合征的方法
US20100234318A1 (en) Ophthalmic composition containing alginic acid or salt thereof
JPWO2009035034A1 (ja) 眼科用組成物
US20050267088A1 (en) Compositions for treating hyperemia
JP2013234199A (ja) 自己保存性水性医薬品組成物
JPWO2009041549A1 (ja) 眼科用組成物
CA2947274C (en) Ophthalmic compositions and methods for treating eyes
JP6373805B2 (ja) コンタクトレンズ装着点眼液
EP2349251B1 (en) Topical formulations with a tertiary amine oxide
US20040028645A1 (en) Artificial tear composition adapted to be used with contact lenses
CA2758858C (en) Aqueous ophthalmic compositions containing anionic therapeutic agents
EP2800573B1 (en) Ophthalmic composition
JP2025076107A (ja) 人工涙液型点眼剤組成物
JP2023166315A (ja) 眼科組成物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND PATENTEE NAME FROM ADVANCED MEDICAL OPTICS, INC. TO ABBOTT MEDICAL OPTICS INC.

HB Alteration of name in register

Owner name: JOHNSON & JOHNSON SURGICAL VISION, INC.

Free format text: FORMER NAME(S): ABBOTT MEDICAL OPTICS INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired